This study investigates pancreatic cancer. The purpose of this study is to establish a sero-library to assess several potentially useful serum biomarkers for early diagnosis.
The study focuses on evaluating the effectiveness of serum biomarkers, such as adiponectin, in detecting pancreatic cancer at an early stage.
- Who can participate: Adults with documented adenocarcinoma, except if the tumor is immediately resectable, may participate. Additionally, adults aged 40 and older undergoing digestive endoscopy for non-cancer reasons are eligible. Participants must be affiliated with a social security system.
- Study details: Participants will provide blood samples to researchers to evaluate serum biomarkers for early cancer detection.